Norton Rose Fulbright, seven US lawyers among 2023 top PTAB practitioners
Vereinigte Staaten | Press release - Recognition | Oktober 2023
Norton Rose Fulbright and US Head of IP Transactions and Patents, Eagle Robinson, have been recognized in Patexia's PTAB 2023 Intelligence Report, with the firm ranked among the top 50 for the most active law firms and Eagle ranked as a top 10 best performing lawyer in PTAB trials representing petitioners before the Patent Trial and Appeal Board (PTAB) in 2023.
Robinson, whose practice focuses on PTAB trials and providing strategic IP guidance, was additionally ranked in the top 50 best performing attorneys overall and top 50 most active attorneys representing petitioners, as well as among the top most-active attorneys overall.
Patexia also recognized the outstanding performance of the following US attorneys in rankings accompanying the report:
- Jeremy Albright (top 8 percent of attorneys representing petitioners; top 8 percent of attorneys overall)
- Mark Garrett (top 12 percent of attorneys representing petitioners; top 15 percent of attorneys overall)
- Daniel Leventhal (top 4 percent of attorneys representing petitioners; top 5 percent of attorneys overall)
- Michael Pohl (top 8 percent of attorneys representing petitioners; top 8 percent of attorneys overall)
- Michael V. Solomita (top 10 percent of attorneys representing patent owners; top 17 percent of attorneys overall)
- Richard S. Zembek (top 4 percent of attorneys representing petitioners; top 4 percent of attorneys overall)
The PTAB Intelligence Report, expanded this year from the IPR Intelligence Report, covers a broader spectrum of proceedings including the addition of Post-Grant Review (PGR), Covered Business Method (CBM) and Derivative (DER) proceedings over a five-year period.
Patexia, which provides analysis of patent and lawsuit data and analysis of the IP sector, analyzed the performance and activity of law firms in all PTAB proceedings, comparing and providing rankings for the top firms and lawyers representing petitioners and patent owners.
Learn more about Norton Rose Fulbright's PTAB practice.